APA (7th ed.) Citation

Peng-Fei Zhang, Peng-Fei Zhang, Dan Xie, Dan Xie, Qiu Li, & Qiu Li. (2021). Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Peng-Fei Zhang, Peng-Fei Zhang, Dan Xie, Dan Xie, Qiu Li, and Qiu Li. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Peng-Fei Zhang, et al. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A., 2021.